Machine learning model for differentiating xanthogranulomatous cholecystitis and gallbladder cancer in multicenter largescale study.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 41034367.
- Also identified by DOI 10.1038/s41746-025-01991-7 and PMC identifier 12488932.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Preoperative differentiation between xanthogranulomatous cholecystitis (XGC) and gallbladder cancer (GBC) remains challenging due to overlapping clinical and imaging features. This multicenter retrospective study developed a machine learning (ML) model, LIDGAX, using preoperative clinical, imaging, and laboratory data from 1246 patients (554 XGC, 692 GBC). Twelve variables were identified as independent predictors via multivariate logistic regression and least absolute shrinkage and selection operator analyses. LIDGAX achieved area under the curve (AUC) values of 0.94 (internal validation) and 0.88 (external testing), outperforming the other five ML models. Calibration and decision curve analyses demonstrated its superior clinical utility. Compared to six radiologists, LIDGAX improved sensitivity (1.2-8.5%), specificity (0.0-4.6%), and balanced accuracy (1.8-6.6%), while reducing average diagnostic time per patient by 30.44-35.76 s. LIDGAX was deployed on an open-source online platform, maintaining high performance (AUC 0.95, accuracy 0.92). This non-invasive tool shows strong potential for clinical translation in preoperative differentiation of XGC and GBC.